Page last updated: 2024-11-07

1,4-diaminobutanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,4-diaminobutanone: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151733
CHEMBL ID4160234
SCHEMBL ID2179702
MeSH IDM0062980

Synonyms (11)

Synonym
einecs 222-914-0
nsc 60541
1,4-diaminobutan-2-one
2-butanone, 1,4-diamino-
1,4-diaminobutanone
1,4-diamino-2-butanone
13123-70-1
AKOS006220478
SCHEMBL2179702
DTXSID30927135
CHEMBL4160234

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Electron microscopic examination of control versus DAB-treated trichomonads did not reveal any adverse effects on the number and integrity of hydrogenosomes."( Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity.
Alderete, JF; Benchimol, M; Garcia, AF, 2005
)
0.33
" Pre-addition of either catalase (5 μM) or aminoguanidine (20 mM) was observed to partially inhibit the toxic effects of DAB to the cells, while N-acetyl-L-cysteine (NAC, 5 mM) or reduced glutathione (GSH, 5 mM) provided almost complete protection against DAB."( Cytotoxicity of 1,4-diamino-2-butanone, a putrescine analogue, to RKO cells: mechanism and redox imbalance.
Bechara, EJ; Boiani, M; Marnett, LJ; Soares, CO, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1353319Antiparasitic activity against Leishmania amazonensis MHOM/Br/75/Josefa promastigotes by light microscopic method2018European journal of medicinal chemistry, Mar-10, Volume: 147Targeting polyamine transport in Trypanosoma cruzi.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.90)18.7374
1990's10 (32.26)18.2507
2000's9 (29.03)29.6817
2010's8 (25.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.24 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]